Formosa Pharmaceuticals and AimMax Therapeutics announce NDA Submission to USFDA for APP13007
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
The collaboration between CORONA and Ferring will cater to patients across India
Pheezee is designed to assess musculoskeletal and neuromuscular health.
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
SÜDPACK is setting standards in terms of both performance and sustainability
Gafchromic films support patient care in oncology
Subscribe To Our Newsletter & Stay Updated